Virtual Auditing in a Post-COVID World of Digital Compliance

Global Medical Device Podcast · 18 Feb 2021 · 30m · Episode 180

What this episode covers

Colleen Hittle, founder of ProVeritas Partners, discusses the shift to virtual auditing and compliance in the medical device industry during the pandemic. She explains that while notified bodies adopted remote monitoring early, the FDA was slower to embrace virtual inspections, creating challenges in assessing facility context and human interaction. Hittle outlines practical workarounds, such as using video walkthroughs and pre-recorded process videos, to simulate on-site presence, and argues that virtual audits will likely remain a permanent part of the regulatory toolkit due to cost and talent retention benefits.

Other shows on the same ground, closest first.

  • Let's Combinate · 45m

    253 - FDA Is Making Big Changes to Its Inspection Approach

    Eric Pittman, former Bioresearch Monitoring West Division Director at the FDA and now VP at Project Farma, explains the FDA's transition from a specialized program-aligned inspection model back to a broader, medical-product-specific generalist model under the new Office of Investigations and Inspections (OII). He details the operational differences between routine inspections under Section 704 and undercover investigations under Section 702, emphasizing that investigators prioritize human subject safety over minor regulatory technicalities. Pittman advises industry to focus on the FDA’s Investigations Operations Manual (IOM) and specific compliance programs rather than cosmetic facility improvements, noting that the end of QSIT has shifted focus to broader process evaluation.

  • Moore's Lobby · 1h 19m

    Ep. 15 | The Emergence of the Virtual Supply Chain in a COVID-19 World

    Mark Burr-Lonnon of Mouser Electronics, Dave Doherty of Digi-Key, and Frank McKay of Jabil discuss how the COVID-19 pandemic accelerated the shift to virtual supply chains and e-commerce in the electronics industry. The panelists explain how distributors are adapting by stocking more inventory for new product introductions (NPI) and providing rich technical content to support remote engineers, while Jabil emphasizes the importance of early engagement in design for manufacturing and supply chain transparency. They highlight the resilience of the supply chain despite disruptions in commercial air freight and regional lockdowns, noting that engineers are increasingly relying on digital tools and anonymous purchasing to navigate component shortages.

  • Let's Combinate · 52m

    128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture

    Vin Cafiso, former FDA Consumer Safety Officer and Managing Consultant at Practical Compliance Results, discusses the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and its impact on small medical device companies. He explains how FDA inspection methodologies are shifting from issue-focused 483s to process-based QSET audits, emphasizing the importance of understanding quality culture through simple engagement rather than rigid metrics. Cafiso shares insights from his career at companies like BD and Smith & Nephew, highlighting how starting as an investigator builds a strong foundation for industry roles by providing a broad view of quality systems across diverse products and company sizes.

  • Let's Combinate · 15m

    188 – Certified Quality Auditor(CQA) and Audits in the Future

    Subhi Saadeh, an ISO 13485 certified lead auditor and host of Let's Combinate, discusses the evolving role of auditing in the medical device and pharmaceutical industries. He reflects on his recent acquisition of the Certified Quality Auditor (CQA) credential and outlines the key qualities that distinguish great auditors, such as risk-based decision-making and the ability to trace issues across systems. Saadeh argues that while AI can streamline tasks like trend analysis and traceability, it cannot replace the human judgment, cultural assessment, and adaptability required for effective audits.

  • Let's Combinate · 13m

    215 - Why Aren’t Technical People Leading Drug-Device Audits?

    Subhi Saadeh, Founder of Let’s Combinate BioWorks, explains why engineers in pharma and medical devices should become auditors, arguing that technical expertise combined with audit methodology creates the most effective auditors. He details how auditing provides a system-level perspective, revealing how design decisions ripple through Quality Management Systems (QMS) and identifying systemic root causes that isolated engineering work often misses. Saadeh addresses common misconceptions, such as the view that auditing is merely bureaucratic paperwork, and reframes it as a critical tool for building regulatory fluency and career versatility across industries like aerospace and medical devices. He concludes with practical steps for engineers to enter the field, including shadowing internal audits, learning audit frameworks like ISO 13485, and seeking mentorship from experienced professionals.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.